Timing of Mobilization on Delirium in Patients After Cardiac Surgery
NCT ID: NCT06069349
Last Updated: 2023-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-09-15
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Trajectory and Influencing Factors of Cognitive Level in ICU Delirium Patients After Transfer Out of the ICU
NCT06674603
Rehabilitation Intervention on Prevention of Postoperative Delirium
NCT03949114
The Study of Postoperative Delirium and Glymphatic System Function in Cardiac Surgery
NCT06901479
Relationship Between Postoperative Delirium and Heart Function in Valvular Surgery
NCT05211934
Machine Learning Algorithm for Predicting Postoperative Delirium in Elderly Patients After Thoracic Surgery
NCT06226480
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Early mobilization is recommended because it is effective in improving symptoms for patients after cardiac surgery. However, the optimal timing of mobilization for postoperative patients is not unclear. How early is early? As early mobilization in the ICU is safe and may reduce healthcare costs, the goal was to assess the effect of early mobilization in the ICU on the incidence and duration of delirium.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
usual treatment
usual treatment
Patients are not allowed to exercise Early Rehabilitation
Early mobilization
early mobilization in the ICU
Early Rehabilitation
Early Rehabilitation for patients after cardiac surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early Rehabilitation
Early Rehabilitation for patients after cardiac surgery
usual treatment
Patients are not allowed to exercise Early Rehabilitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Patients agree to participate in clinical research and sign informed consent before the start of the study
Exclusion Criteria
* 1\. Pregnant and lactating women
* 2\. There are contraindications to getting out of bed：
* 2.1 Low cardiac output syndrome
* (1) Application of IABP or PCPS (percutaneous cardiopulmonary support)
* (2) High doses of vasoactive drugs (norepinephrine\> 0.5ug/kg.min)
* (3) SBP\<=80mmHg
* (4) Acrocyanosis, wet and cold
* (5) Metabolic acidosis
* (6) Urine output less than 0.5ml/kg.h for more than 2 hours
* 2.2 Heart rate greater than or equal to 120 beats per minute at rest
* 2.3 Orthostatic hypotension (systolic blood pressure less than 80 mmHg after postural change)
* 2.4 Presence of arrhythmias leading to a drop in blood pressure (e.g., decreased blood pressure due to new-onset atrial fibrillation)
* 2.5 Difficulty breathing at rest or respiratory rate greater than 30 breaths per minute
* 2.6 Postoperative bleeding (200ml in 2-3 hours)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jingyuan,Xu
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jingyuan,Xu
Deputy Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jingyuan Xu, M.D.
Role: STUDY_DIRECTOR
Study Principal Investigator Southeast University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongda hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jingyuan Xu, M.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023ZDSYLL356-P01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.